Seeing Is Believing
Currently out of the existing stock ratings of Ritu Baral, 103 are a BUY (86.55%), 14 are a HOLD (11.76%), 2 are a SELL (1.68%).
Analyst Ritu Baral, currently employed at TD COWEN, carries an average stock price target met ratio of 55.8% that have a potential upside of 43.77% achieved within 508 days.
Ritu Baral’s has documented 260 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on INSM, Insmed at 01-Oct-2025.
Analyst best performing recommendations are on SAGE (SAGE THERAPEUTIC).
The best stock recommendation documented was for SAGE (SAGE THERAPEUTIC) at 7/30/2024. The price target of $10 was fulfilled within 2 days with a profit of $0.8 (7.41%) receiving and performance score of 37.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$33
$12.11 (57.97%)
$34
22 days ago
(28-Sep-2025)
8/13 (61.54%)
$11.68 (54.78%)
113
Buy
$28
$7.11 (34.04%)
$30
27 days ago
(23-Sep-2025)
0/10 (0%)
$6.74 (31.70%)
Buy
$39
$18.11 (86.69%)
$35
1 months 10 days ago
(10-Sep-2025)
7/12 (58.33%)
$14.8 (61.16%)
671
Buy
$39
$18.11 (86.69%)
$32
1 months 12 days ago
(08-Sep-2025)
1/5 (20%)
$14.16 (57.00%)
349
Hold
$24
$3.11 (14.89%)
$23
2 months 14 days ago
(06-Aug-2025)
10/13 (76.92%)
$-0.4 (-1.64%)
157
Which stock is Ritu Baral is most bullish on?
Which stock is Ritu Baral is most reserved on?
What Year was the first public recommendation made by Ritu Baral?